Register for May 22, 2018 Webinar


Science & Innovation Theater Webinar 


FDA Companion Diagnostic Testing and Implications for Pharmacy Medical Directors
Sponsored by Myriad Genetics Incorporated

Tuesday, May 22, 2018, 2-3pm EDT

FDA designation of a companion diagnostic test has key implications for pharmacy payers. Coordinating medical benefit and pharmacy policies regarding companion diagnostics and pharmaceuticals may be a worthwhile consideration for your plan.

The presentations within this webinar will discuss the OlympiAD data and the resulting FDA companion diagnostic indication for BRACAnalysis CDx in considering treatment options for patients with metastatic breast cancer. Results and analysis from a survey distributed to AMCP members will be discussed within the webinar.


  • Johnathan Lancaster, MD, PhD
    Chief Medical Officer, Myriad Genetics Incorporated
  • Diana Brixner, PhD, RPh, FAMCP
    Professor, Executive Director, Pharmacotherapy Outcomes Research Center
    President Academy of Managed Care Pharmacy

This webinar is sponsored, developed and presented by the sponsor.  The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy. 

Sponsored by:  

   Myriad Logo 

** IMPORTANT: AMCP webinars are limited to the first 500 that join the webinar. However, AMCP will provide a link to the recording and slides to all registrants within a week from the webinar date. The recording and slides of sponsored webinars will be provided if permitted by the sponsor.